Advertisement
Advertisement

David E. Szymkowski

David E. Szymkowski is Senior Director of Biotherapeutics at Xencor.

Articles

Advertisement

True Biosimilars Do Not Offer A Compelling Business Case

August 01, 2010

Why the primary defence against biosimilars is to develop better molecules that can be launched quickly.

Advertisement
Advertisement
Advertisement
x